Dafna Capital Management LLC Cardiovascular Systems Inc Transaction History

Dafna Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $1.74 Million - $3.43 Million	93,247 Added 48.13%	286,988 $5.39 Million
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $1.45 Million - $1.89 Million	44,041 Added 29.42%	193,741 $6.36 Million
Q1 2021 May 17, 2021	SELL	$37.29 - $47.19 $55,935 - $70,785	-1,500 Reduced 0.99%	149,700 $5.74 Million
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $3.03 Million - $4.26 Million	100,000 Added 195.31%	151,200 $4.77 Million
Q1 2020 May 15, 2020	BUY	$30.0 - $54.18 $150,000 - $270,900	5,000 Added 10.82%	51,200 $1.8 Million
Q3 2019 Nov 14, 2019	SELL	$42.06 - $51.64 $210,300 - $258,200	-5,000 Reduced 9.77%	46,200 $2.2 Million
Q2 2019 Aug 14, 2019	SELL	$33.93 - $43.66 $169,650 - $218,299	-5,000 Reduced 8.9%	51,200 $2.2 Million
Q1 2019 May 15, 2019	SELL	$26.74 - $41.32 $267,400 - $413,200	-10,000 Reduced 15.11%	56,200 $2.17 Million
Q4 2018 Feb 14, 2019	BUY	$25.26 - $38.43 $252,600 - $384,300	10,000 Added 17.79%	66,200 $1.89 Million
Q3 2018 Nov 14, 2018	SELL	$33.27 - $39.25 $99,810 - $117,750	-3,000 Reduced 5.07%	56,200 $2.2 Million
Q2 2018 Aug 13, 2018	BUY	$21.73 - $33.15 $1.29 Million - $1.96 Million	59,200 New	59,200 $1.92 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.